DOI: 10.1016/j.cbpa.2004.04.003. Pursuing the leadlikeness concept in pharmaceutical research

Pursuing the leadlikeness concept in pharmaceutical research

10.1016/j.cbpa.2004.04.003

Crossref journal-article

Elsevier BV

Current Opinion in Chemical Biology (78)

Bibliography

Hann, M. M., & Oprea, T. I. (2004). Pursuing the leadlikeness concept in pharmaceutical research. Current Opinion in Chemical Biology, 8(3), 255â263.

Authors 2

Mike M Hann (first)
Tudor I Oprea (additional)

References 54 Referenced 439

10.1016/S1359-6446(98)01252-5 / Drug Discov Today / Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D by Drews (1998)
10.1126/science.287.5460.1960 / Science / Drug discovery: a historical perspective by Drews (2000)
10.1177/014107680009300702 / J R Soc Med / Innovation in the pharmaceutical industry by Horrobin (2000)
Sneader W: Drug prototypes and their exploitation. Chichester: Wiley, 1996.
{'key': '10.1016/j.cbpa.2004.04.003_BIB5', 'first-page': '189', 'article-title': 'Serendipity and structured research in drug discovery', 'volume': '30', 'author': 'DeStevens', 'year': '1986', 'journal-title': 'Prog Drug Res'} / Prog Drug Res / Serendipity and structured research in drug discovery by DeStevens (1986)
10.1021/ci000403i / J Chem Inf Comput Sci / Molecular complexity and its impact on the probability of finding leads for drug discovery by Hann (2001)
10.1021/ci010366a / J Chem Inf Comput Sci / Is there a difference between leads and drugs? A historical perspective by Oprea (2001)
Oprea TI: Cheminformatics and the quest for leads in drug discovery. In Handbook of Cheminformatics vol. 4. Edited by Gasteiger J, Engel T. New York: VCH-Wiley; 2003:1508-1531. (10.1002/9783527618279.ch44b)
10.1016/S0065-7743(08)61100-8 / Annu Rep Med Chem / Cheminformatics: what is it and how does it impact drug discovery by Brown (1998)
10.1038/nrd1012 / Nat Rev Drug Discov / Modern biomedical research: an internally self-consistent universe with little contact with medical reality? by Horrobin (2003)
10.1016/S0169-409X(96)00423-1 / Adv Drug Deliv Rev / Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings by Lipinski (1997)
Boyd DB: Progress in the rational design of therapeutically interesting compounds. In Rational Molecular Design in Drug Research. Edited by Liljefors T, Jorgensen FS, Krogsgaard-Larsen P. Copenhagen: MUNKSGAARD; 1998:15-29.
10.1023/A:1020877402759 / J Comput Aided Mol Des / Lead structure searching: are we looking at the appropriate property? by Oprea (2002)
Machin P: Designing drugs - where next? In EuroQSAR 2002 - Designing Drugs and Crop Protectants: Processes, Problems and Solutions. Edited by Ford M, Livingstone D, Dearden J, Van de Waterbeemd H. New York: Blackwell Publishing; 2003:1-4.
Oprea TI, Li J, Muresan S, Mattes KC: High throughput and virtual screening: choosing the appropriate leads. In EuroQSAR 2002 - Designing Drugs and Crop Protectants: Processes, Problems and Solutions. Edited by Ford M, Livingstone D, Dearden J, Van de Waterbeemd H. New York: Blackwell Publishing; 2003:40-47.
10.1016/S1359644602025722 / Drug Discov Today / Nonleadlikeness and leadlikeness in biochemical screening by Rishton (2003)
10.1021/jm010533y / J Med Chem / A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening by McGovern (2002)
10.1021/jm010934d / J Med Chem / Development of a virtual screening method for identification of ‘frequent hitters’ in compound libraries by Roche (2002)
10.1177/108705710200700303 / J Biomol Screen / The confirmation rate of primary hits: A predictive model by Fogel (2002)
10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6 / Med Res Rev / The art and practice of structure-based drug design: a molecular modeling perspective by Bohacek (1996)
The ChemNavigator homepage on http://www.chemnavigator.com
According to the PhRMA: (Pharmaceutical Research and Manufacturers of America) website on http://www.phrma.org/issues/researchdev/
Weininger D: Combinatorics of small molecular structures. In Encyclopedia of Computational Chemistry, Vol. 1. Edited by Von Ragué Schleyer P. New York: Wiley; 1998:425-430. (10.1002/0470845015.cna014m)
10.1002/jhet.5570370324 / J Heterocycl Chem / Finding drug candidates in virtual and lost/emerging chemistry by De Laet (2000)
Ajay, Walters WP, Murcko MA: Can we learn to distinguish between ‘drug-like’ and ‘nondrug-like’ molecules?. J Med Chem 1998, 41:3314-3324. (10.1021/jm970666c)
10.1021/jm9706776 / J Med Chem / A scoring scheme for discriminating between drugs and nondrugs by Sadowski (1998)
WDI: the Derwent World Drug Index, is available from Daylight Chemical Information Systems at http://www.daylight.com
MDDR and ACD are available from MDL Information Systems: http://www.mdli.com/products/finders/database_finder/index.jsp. MDDR is developed in cooperation with Prous Science Publishers at http://www.prous.com/index.html
10.1021/ci990266t / J Chem Inf Comput Sci / Potential drugs and nondrugs: prediction and identification of important structural features by Wagener (2000)
10.1021/ci0003810 / J Chem Inf Comput Sci / Improving the odds in discriminating “druglike” from “nondruglike” compounds by Frimurer (2000)
10.1021/jm011027b / J Med Chem / Descriptors, physical properties and drug-likeness by Brüstle (2002)
10.1023/A:1008130001697 / J Comput Aided Mol Des / Property distribution of drug-related chemical databases by Oprea (2000)
10.1021/jm030267j / J Med Chem / Characteristic physical properties and structural fragments of marketed oral drugs by Vieth (2004)
10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U / Angew Chem Int Ed Engl / The design of leadlike combinatorial libraries by Teague (1999)
10.1016/S0960-894X(02)00244-5 / Bioorg Med Chem Lett / Drugs, leads, and drug-likeness: an analysis of some recently launched drugs by Proudfoot (2002)
10.1002/anie.200200539 / Angew Chem Int Ed Engl / Application and limitations of X-ray crystallographic data in structure-based ligand and drug design by Davis (2003)
10.1038/nrd1110 / Nat Rev Drug Discov / Predicting therapeutic value in the lead optimization phase of drug discovery by Kenakin (2003)
10.1016/S1056-8719(00)00107-6 / J Pharmacol Toxicol Methods / Drug-like properties and the causes of poor solubility and poor permeability by Lipinski (2000)
10.1038/nrd1156 / Nat Rev Drug Discov / Drug research: myths, hype and reality by Kubinyi (2003)
The WOMBAT: (World of Molecular BioAcTivity) database, is available from Sunset Molecular Discovery at http://www.sunsetmolecular.com
10.1021/cr00020a001 / Chem Rev / Estimating LogPoct from structures by Leo (1993)
10.1073/pnas.96.18.9997 / Proc Natl Acad Sci USA / The maximal affinity of ligands by Kuntz (1999)
10.3390/70100051 / Molecules / Virtual screening in lead discovery: a viewpoint by Oprea (2002)
10.1021/ci020055f / J Chem Inf Comput Sci / Consideration of molecular weight during compound selection in virtual target-based database screening by Pan (2003)
Oprea TI, Bologa C, Olah M: Compound selection for virtual screening. In Virtual Screening in Drug Discovery. Edited by Alvarez JC, Shoichet B. New York: Marcel Dekker; 2004:in press. (10.1201/9781420028775.pt2)
10.1016/S1359-6446(02)02245-6 / Drug Discov Today / Structure-based screening of low-affinity compounds by Carr (2002)
Milburn MV: Drug discovery on a proteomic scale. Abstracts of Papers, 224th ACS National Meeting, Boston, MA, USA, August 18–22, 2002, COMP-042.
10.1107/S0909049503023975 / J Synchrotron Radiat / Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design by Moore (2004)
Hann MM, Leach AR, Green DVS: Computational chemistry, molecular complexity and screening set design. In Cheminformatics in Drug Discovery Edited by Oprea TI. New York: Wiley-VCH: 2004:in press. (10.1002/3527603743.ch3)
10.1021/ci0003855 / J Chem Inf Comput Sci / Where are the GaPs? A rational approach to monomer acquisition and selection by Leach (2000)
10.1016/S1359-6446(03)02831-9 / Drug Discov Today / A ‘Rule of Three’ for fragment-based lead discovery? by Congreve (2003)
10.1016/S1359-6446(03)03007-1 / Drug Discov Today / Molecular recognition: the fragment approach in lead generation by Fattori (2004)
10.1002/jps.10386 / J Pharm Sci / Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs by Tronde (2003)
10.2174/138620704772884832 / Comb Chem High Throughput Screen / Design of a compound screening collection for use in high-throughput screening by Harper (2004)

Dates

Type	When
Created	21 years, 3 months ago (May 8, 2004, 6:30 a.m.)
Deposited	1 year, 7 months ago (Jan. 13, 2024, 4:56 a.m.)
Indexed	3 weeks, 5 days ago (July 26, 2025, 5:21 a.m.)
Issued	21 years, 2 months ago (June 1, 2004)
Published	21 years, 2 months ago (June 1, 2004)
Published Print	21 years, 2 months ago (June 1, 2004)

Funders 0

None

BibTeX

@article{Hann_2004, title={Pursuing the leadlikeness concept in pharmaceutical research}, volume={8}, ISSN={1367-5931}, url={http://dx.doi.org/10.1016/j.cbpa.2004.04.003}, DOI={10.1016/j.cbpa.2004.04.003}, number={3}, journal={Current Opinion in Chemical Biology}, publisher={Elsevier BV}, author={Hann, Mike M and Oprea, Tudor I}, year={2004}, month=jun, pages={255–263} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        7,
        26
      ]
    ],
    "date-time": "2025-07-26T09:21:07Z",
    "timestamp": 1753521667910
  },
  "reference-count": 54,
  "publisher": "Elsevier BV",
  "issue": "3",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2004,
            6,
            1
          ]
        ],
        "date-time": "2004-06-01T00:00:00Z",
        "timestamp": 1086048000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2004,
        6
      ]
    ]
  },
  "DOI": "10.1016/j.cbpa.2004.04.003",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        5,
        8
      ]
    ],
    "date-time": "2004-05-08T10:30:56Z",
    "timestamp": 1084012256000
  },
  "page": "255-263",
  "source": "Crossref",
  "is-referenced-by-count": 439,
  "title": "Pursuing the leadlikeness concept in pharmaceutical research",
  "prefix": "10.1016",
  "volume": "8",
  "author": [
    {
      "given": "Mike M",
      "family": "Hann",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Tudor I",
      "family": "Oprea",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB1",
      "doi-asserted-by": "crossref",
      "first-page": "491",
      "DOI": "10.1016/S1359-6446(98)01252-5",
      "article-title": "Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D",
      "volume": "3",
      "author": "Drews",
      "year": "1998",
      "journal-title": "Drug Discov Today"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "1960",
      "DOI": "10.1126/science.287.5460.1960",
      "article-title": "Drug discovery: a historical perspective",
      "volume": "287",
      "author": "Drews",
      "year": "2000",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "341",
      "DOI": "10.1177/014107680009300702",
      "article-title": "Innovation in the pharmaceutical industry",
      "volume": "93",
      "author": "Horrobin",
      "year": "2000",
      "journal-title": "J R Soc Med"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB4",
      "unstructured": "Sneader W: Drug prototypes and their exploitation. Chichester: Wiley, 1996."
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB5",
      "first-page": "189",
      "article-title": "Serendipity and structured research in drug discovery",
      "volume": "30",
      "author": "DeStevens",
      "year": "1986",
      "journal-title": "Prog Drug Res"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB6",
      "doi-asserted-by": "crossref",
      "first-page": "856",
      "DOI": "10.1021/ci000403i",
      "article-title": "Molecular complexity and its impact on the probability of finding leads for drug discovery",
      "volume": "41",
      "author": "Hann",
      "year": "2001",
      "journal-title": "J Chem Inf Comput Sci"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "1308",
      "DOI": "10.1021/ci010366a",
      "article-title": "Is there a difference between leads and drugs? A historical perspective",
      "volume": "41",
      "author": "Oprea",
      "year": "2001",
      "journal-title": "J Chem Inf Comput Sci"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB8",
      "doi-asserted-by": "crossref",
      "unstructured": "Oprea TI: Cheminformatics and the quest for leads in drug discovery. In Handbook of Cheminformatics vol. 4. Edited by Gasteiger J, Engel T. New York: VCH-Wiley; 2003:1508-1531.",
      "DOI": "10.1002/9783527618279.ch44b"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB9",
      "doi-asserted-by": "crossref",
      "first-page": "375",
      "DOI": "10.1016/S0065-7743(08)61100-8",
      "article-title": "Cheminformatics: what is it and how does it impact drug discovery",
      "volume": "33",
      "author": "Brown",
      "year": "1998",
      "journal-title": "Annu Rep Med Chem"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB10_1",
      "doi-asserted-by": "crossref",
      "first-page": "151",
      "DOI": "10.1038/nrd1012",
      "article-title": "Modern biomedical research: an internally self-consistent universe with little contact with medical reality?",
      "volume": "2",
      "author": "Horrobin",
      "year": "2003",
      "journal-title": "Nat Rev Drug Discov"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB11",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "DOI": "10.1016/S0169-409X(96)00423-1",
      "article-title": "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings",
      "volume": "23",
      "author": "Lipinski",
      "year": "1997",
      "journal-title": "Adv Drug Deliv Rev"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB12",
      "unstructured": "Boyd DB: Progress in the rational design of therapeutically interesting compounds. In Rational Molecular Design in Drug Research. Edited by Liljefors T, Jorgensen FS, Krogsgaard-Larsen P. Copenhagen: MUNKSGAARD; 1998:15-29."
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "325",
      "DOI": "10.1023/A:1020877402759",
      "article-title": "Lead structure searching: are we looking at the appropriate property?",
      "volume": "16",
      "author": "Oprea",
      "year": "2002",
      "journal-title": "J Comput Aided Mol Des"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB14",
      "unstructured": "Machin P: Designing drugs - where next? In EuroQSAR 2002 - Designing Drugs and Crop Protectants: Processes, Problems and Solutions. Edited by Ford M, Livingstone D, Dearden J, Van de Waterbeemd H. New York: Blackwell Publishing; 2003:1-4."
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB15",
      "unstructured": "Oprea TI, Li J, Muresan S, Mattes KC: High throughput and virtual screening: choosing the appropriate leads. In EuroQSAR 2002 - Designing Drugs and Crop Protectants: Processes, Problems and Solutions. Edited by Ford M, Livingstone D, Dearden J, Van de Waterbeemd H. New York: Blackwell Publishing; 2003:40-47."
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB16_1",
      "doi-asserted-by": "crossref",
      "first-page": "86",
      "DOI": "10.1016/S1359644602025722",
      "article-title": "Nonleadlikeness and leadlikeness in biochemical screening",
      "volume": "8",
      "author": "Rishton",
      "year": "2003",
      "journal-title": "Drug Discov Today"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB17_1",
      "doi-asserted-by": "crossref",
      "first-page": "1712",
      "DOI": "10.1021/jm010533y",
      "article-title": "A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening",
      "volume": "45",
      "author": "McGovern",
      "year": "2002",
      "journal-title": "J Med Chem"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB18_1",
      "doi-asserted-by": "crossref",
      "first-page": "137",
      "DOI": "10.1021/jm010934d",
      "article-title": "Development of a virtual screening method for identification of \u2018frequent hitters\u2019 in compound libraries",
      "volume": "45",
      "author": "Roche",
      "year": "2002",
      "journal-title": "J Med Chem"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "175",
      "DOI": "10.1177/108705710200700303",
      "article-title": "The confirmation rate of primary hits: A predictive model",
      "volume": "7",
      "author": "Fogel",
      "year": "2002",
      "journal-title": "J Biomol Screen"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB20",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "DOI": "10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6",
      "article-title": "The art and practice of structure-based drug design: a molecular modeling perspective",
      "volume": "16",
      "author": "Bohacek",
      "year": "1996",
      "journal-title": "Med Res Rev"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB21",
      "unstructured": "The ChemNavigator homepage on http://www.chemnavigator.com"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB22",
      "unstructured": "According to the PhRMA: (Pharmaceutical Research and Manufacturers of America) website on http://www.phrma.org/issues/researchdev/"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB23",
      "doi-asserted-by": "crossref",
      "unstructured": "Weininger D: Combinatorics of small molecular structures. In Encyclopedia of Computational Chemistry, Vol. 1. Edited by Von Ragu\u00e9 Schleyer P. New York: Wiley; 1998:425-430.",
      "DOI": "10.1002/0470845015.cna014m"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "669",
      "DOI": "10.1002/jhet.5570370324",
      "article-title": "Finding drug candidates in virtual and lost/emerging chemistry",
      "volume": "37",
      "author": "De Laet",
      "year": "2000",
      "journal-title": "J Heterocycl Chem"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB25",
      "doi-asserted-by": "crossref",
      "unstructured": "Ajay, Walters WP, Murcko MA: Can we learn to distinguish between \u2018drug-like\u2019 and \u2018nondrug-like\u2019 molecules?. J Med Chem 1998, 41:3314-3324.",
      "DOI": "10.1021/jm970666c"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "3325",
      "DOI": "10.1021/jm9706776",
      "article-title": "A scoring scheme for discriminating between drugs and nondrugs",
      "volume": "41",
      "author": "Sadowski",
      "year": "1998",
      "journal-title": "J Med Chem"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB27",
      "unstructured": "WDI: the Derwent World Drug Index, is available from Daylight Chemical Information Systems at http://www.daylight.com"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB28",
      "unstructured": "MDDR and ACD are available from MDL Information Systems: http://www.mdli.com/products/finders/database_finder/index.jsp. MDDR is developed in cooperation with Prous Science Publishers at http://www.prous.com/index.html"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB29",
      "doi-asserted-by": "crossref",
      "first-page": "280",
      "DOI": "10.1021/ci990266t",
      "article-title": "Potential drugs and nondrugs: prediction and identification of important structural features",
      "volume": "40",
      "author": "Wagener",
      "year": "2000",
      "journal-title": "J Chem Inf Comput Sci"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB30",
      "doi-asserted-by": "crossref",
      "first-page": "1315",
      "DOI": "10.1021/ci0003810",
      "article-title": "Improving the odds in discriminating \u201cdruglike\u201d from \u201cnondruglike\u201d compounds",
      "volume": "40",
      "author": "Frimurer",
      "year": "2000",
      "journal-title": "J Chem Inf Comput Sci"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB31_1",
      "doi-asserted-by": "crossref",
      "first-page": "3345",
      "DOI": "10.1021/jm011027b",
      "article-title": "Descriptors, physical properties and drug-likeness",
      "volume": "45",
      "author": "Br\u00fcstle",
      "year": "2002",
      "journal-title": "J Med Chem"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB32",
      "doi-asserted-by": "crossref",
      "first-page": "251",
      "DOI": "10.1023/A:1008130001697",
      "article-title": "Property distribution of drug-related chemical databases",
      "volume": "14",
      "author": "Oprea",
      "year": "2000",
      "journal-title": "J Comput Aided Mol Des"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB33_1",
      "doi-asserted-by": "crossref",
      "first-page": "224",
      "DOI": "10.1021/jm030267j",
      "article-title": "Characteristic physical properties and structural fragments of marketed oral drugs",
      "volume": "47",
      "author": "Vieth",
      "year": "2004",
      "journal-title": "J Med Chem"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB34",
      "doi-asserted-by": "crossref",
      "first-page": "3743",
      "DOI": "10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U",
      "article-title": "The design of leadlike combinatorial libraries",
      "volume": "38",
      "author": "Teague",
      "year": "1999",
      "journal-title": "Angew Chem Int Ed Engl"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB35_1",
      "doi-asserted-by": "crossref",
      "first-page": "1647",
      "DOI": "10.1016/S0960-894X(02)00244-5",
      "article-title": "Drugs, leads, and drug-likeness: an analysis of some recently launched drugs",
      "volume": "12",
      "author": "Proudfoot",
      "year": "2002",
      "journal-title": "Bioorg Med Chem Lett"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB36_1",
      "doi-asserted-by": "crossref",
      "first-page": "2718",
      "DOI": "10.1002/anie.200200539",
      "article-title": "Application and limitations of X-ray crystallographic data in structure-based ligand and drug design",
      "volume": "42",
      "author": "Davis",
      "year": "2003",
      "journal-title": "Angew Chem Int Ed Engl"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB37_1",
      "doi-asserted-by": "crossref",
      "first-page": "429",
      "DOI": "10.1038/nrd1110",
      "article-title": "Predicting therapeutic value in the lead optimization phase of drug discovery",
      "volume": "2",
      "author": "Kenakin",
      "year": "2003",
      "journal-title": "Nat Rev Drug Discov"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB38",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "DOI": "10.1016/S1056-8719(00)00107-6",
      "article-title": "Drug-like properties and the causes of poor solubility and poor permeability",
      "volume": "44",
      "author": "Lipinski",
      "year": "2000",
      "journal-title": "J Pharmacol Toxicol Methods"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB39_1",
      "doi-asserted-by": "crossref",
      "first-page": "665",
      "DOI": "10.1038/nrd1156",
      "article-title": "Drug research: myths, hype and reality",
      "volume": "2",
      "author": "Kubinyi",
      "year": "2003",
      "journal-title": "Nat Rev Drug Discov"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB40",
      "unstructured": "The WOMBAT: (World of Molecular BioAcTivity) database, is available from Sunset Molecular Discovery at http://www.sunsetmolecular.com"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB41",
      "doi-asserted-by": "crossref",
      "first-page": "1281",
      "DOI": "10.1021/cr00020a001",
      "article-title": "Estimating LogPoct from structures",
      "volume": "5",
      "author": "Leo",
      "year": "1993",
      "journal-title": "Chem Rev"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB42",
      "doi-asserted-by": "crossref",
      "first-page": "9997",
      "DOI": "10.1073/pnas.96.18.9997",
      "article-title": "The maximal affinity of ligands",
      "volume": "96",
      "author": "Kuntz",
      "year": "1999",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB43",
      "doi-asserted-by": "crossref",
      "first-page": "51",
      "DOI": "10.3390/70100051",
      "article-title": "Virtual screening in lead discovery: a viewpoint",
      "volume": "7",
      "author": "Oprea",
      "year": "2002",
      "journal-title": "Molecules"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB44",
      "doi-asserted-by": "crossref",
      "first-page": "267",
      "DOI": "10.1021/ci020055f",
      "article-title": "Consideration of molecular weight during compound selection in virtual target-based database screening",
      "volume": "43",
      "author": "Pan",
      "year": "2003",
      "journal-title": "J Chem Inf Comput Sci"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB45",
      "doi-asserted-by": "crossref",
      "unstructured": "Oprea TI, Bologa C, Olah M: Compound selection for virtual screening. In Virtual Screening in Drug Discovery. Edited by Alvarez JC, Shoichet B. New York: Marcel Dekker; 2004:in press.",
      "DOI": "10.1201/9781420028775.pt2"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB46",
      "doi-asserted-by": "crossref",
      "first-page": "522",
      "DOI": "10.1016/S1359-6446(02)02245-6",
      "article-title": "Structure-based screening of low-affinity compounds",
      "volume": "7",
      "author": "Carr",
      "year": "2002",
      "journal-title": "Drug Discov Today"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB47",
      "unstructured": "Milburn MV: Drug discovery on a proteomic scale. Abstracts of Papers, 224th ACS National Meeting, Boston, MA, USA, August 18\u201322, 2002, COMP-042."
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB48",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "DOI": "10.1107/S0909049503023975",
      "article-title": "Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design",
      "volume": "11",
      "author": "Moore",
      "year": "2004",
      "journal-title": "J Synchrotron Radiat"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB49",
      "doi-asserted-by": "crossref",
      "unstructured": "Hann MM, Leach AR, Green DVS: Computational chemistry, molecular complexity and screening set design. In Cheminformatics in Drug Discovery Edited by Oprea TI. New York: Wiley-VCH: 2004:in press.",
      "DOI": "10.1002/3527603743.ch3"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB50",
      "doi-asserted-by": "crossref",
      "first-page": "1262",
      "DOI": "10.1021/ci0003855",
      "article-title": "Where are the GaPs? A rational approach to monomer acquisition and selection",
      "volume": "40",
      "author": "Leach",
      "year": "2000",
      "journal-title": "J Chem Inf Comput Sci"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB51",
      "doi-asserted-by": "crossref",
      "first-page": "876",
      "DOI": "10.1016/S1359-6446(03)02831-9",
      "article-title": "A \u2018Rule of Three\u2019 for fragment-based lead discovery?",
      "volume": "8",
      "author": "Congreve",
      "year": "2003",
      "journal-title": "Drug Discov Today"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB52_1",
      "doi-asserted-by": "crossref",
      "first-page": "229",
      "DOI": "10.1016/S1359-6446(03)03007-1",
      "article-title": "Molecular recognition: the fragment approach in lead generation",
      "volume": "9",
      "author": "Fattori",
      "year": "2004",
      "journal-title": "Drug Discov Today"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB53_1",
      "doi-asserted-by": "crossref",
      "first-page": "1216",
      "DOI": "10.1002/jps.10386",
      "article-title": "Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs",
      "volume": "92",
      "author": "Tronde",
      "year": "2003",
      "journal-title": "J Pharm Sci"
    },
    {
      "key": "10.1016/j.cbpa.2004.04.003_BIB54",
      "doi-asserted-by": "crossref",
      "first-page": "63",
      "DOI": "10.2174/138620704772884832",
      "article-title": "Design of a compound screening collection for use in high-throughput screening",
      "volume": "7",
      "author": "Harper",
      "year": "2004",
      "journal-title": "Comb Chem High Throughput Screen"
    }
  ],
  "container-title": "Current Opinion in Chemical Biology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1367593104000493?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1367593104000493?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2024,
        1,
        13
      ]
    ],
    "date-time": "2024-01-13T09:56:02Z",
    "timestamp": 1705139762000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1367593104000493"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2004,
        6
      ]
    ]
  },
  "references-count": 54,
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2004,
          6
        ]
      ]
    }
  },
  "alternative-id": [
    "S1367593104000493"
  ],
  "URL": "http://dx.doi.org/10.1016/j.cbpa.2004.04.003",
  "relation": {},
  "ISSN": [
    "1367-5931"
  ],
  "subject": [],
  "container-title-short": "Current Opinion in Chemical Biology",
  "published": {
    "date-parts": [
      [
        2004,
        6
      ]
    ]
  }
}